Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial

BACKGROUND: We compared the albuminuria-lowering effects of Roux-en-Y gastric bypass (RYGB) to best medical treatment in patients with diabetic kidney disease and obesity to determine which treatment is better. METHODS: A 5 year, open-label, single-centre, randomised trial studied patients with diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Ricardo V., Pereira, Tiago Veiga, Aboud, Cristina Mamédio, Zanata Petry, Tarissa Beatrice, Lopes Correa, José Luis, Schiavon, Carlos Aurélio, Pompílio, Carlos Eduardo, Quirino Pechy, Fernando Nogueira, Calmon da Costa Silva, Ana Carolina, Cunha da Silveira, Lívia Porto, Paulo de Paris Caravatto, Pedro, Halpern, Helio, de Lima Jacy Monteiro, Frederico, da Costa Martins, Bruno, Kuga, Rogerio, Sarian Palumbo, Thais Mantovani, Friedman, Allon N., le Roux, Carel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716325/
https://www.ncbi.nlm.nih.gov/pubmed/36467457
http://dx.doi.org/10.1016/j.eclinm.2022.101725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716325/
https://www.ncbi.nlm.nih.gov/pubmed/36467457
http://dx.doi.org/10.1016/j.eclinm.2022.101725

Ejemplares similares